Actively Recruiting
Investigating Myocardial Remodelling in the Failing Human Heart
Led by Oslo University Hospital · Updated on 2025-07-31
200
Participants Needed
1
Research Sites
422 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Despite improvements in therapy, heart failure is a disease with high mortality and accelerating prevalence. To improve patient care, it is necessary to better understand the features and underlying mechanisms of myocardial remodeling; how it manifests in vivo and its underlying cellular and extracellular changes. The RELAX study will offer insight into myocardial remodeling, by comprehensively assessing function and structure of failing human hearts, and investigate its underlying cellular and extracellular changes.
CONDITIONS
Official Title
Investigating Myocardial Remodelling in the Failing Human Heart
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eligible for heart transplantation
- Willingness to participate in the present study and ability to understand and sign the written informed consent
You will not qualify if you...
- Patients under the age of 18.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Oslo, Norway, 0484
Actively Recruiting
Research Team
H
Henrik Dukefoss, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here